Adjusting weight to reflect group differences in Model [General Sta­tis­tics]

posted by dshah  – India/United Kingdom, 2022-03-29 20:40 (753 d 20:12 ago) – Posting: # 22884
Views: 1,797

Dear Balakotu!
As per EMA- In parallel design studies, the treatment groups should be comparable in all known variables that may affect the pharmacokinetics of the active substance (e.g. age, body weight, sex, ethnic origin, smoking status, extensive/poor metabolic status). This is an essential pre-requisite to give validity to the results from such studies.
In general, it is recommended to have balanced between treatment arms.

Complete thread:

UA Flag
 Admin contact
22,988 posts in 4,825 threads, 1,649 registered users;
34 visitors (0 registered, 34 guests [including 8 identified bots]).
Forum time: 16:53 CEST (Europe/Vienna)

As soon as we abandon our own reason, and are content
to rely upon authority, there is no end to our troubles.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz